These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 18656548)

  • 1. Virus-sized vaccine delivery systems.
    Scheerlinck JP; Greenwood DL
    Drug Discov Today; 2008 Oct; 13(19-20):882-7. PubMed ID: 18656548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticles and microparticles as vaccine-delivery systems.
    Singh M; Chakrapani A; O'Hagan D
    Expert Rev Vaccines; 2007 Oct; 6(5):797-808. PubMed ID: 17931159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of nanoparticle-based dry powder pulmonary vaccines.
    Pulliam B; Sung JC; Edwards DA
    Expert Opin Drug Deliv; 2007 Nov; 4(6):651-63. PubMed ID: 17970667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel chitosan derivative nanoparticles enhance the immunogenicity of a DNA vaccine encoding hepatitis B virus core antigen in mice.
    Jiang L; Qian F; He X; Wang F; Ren D; He Y; Li K; Sun S; Yin C
    J Gene Med; 2007 Apr; 9(4):253-64. PubMed ID: 17397104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical adjuvants for plasmid DNA vaccines.
    Greenland JR; Letvin NL
    Vaccine; 2007 May; 25(19):3731-41. PubMed ID: 17350735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of DNA vaccines: an overview on the use of biodegradable polymeric and magnetic nanoparticles.
    Xiang SD; Selomulya C; Ho J; Apostolopoulos V; Plebanski M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(3):205-18. PubMed ID: 20391461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
    Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for DNA vaccine delivery.
    Alpar HO; Papanicolaou I; Bramwell VW
    Expert Opin Drug Deliv; 2005 Sep; 2(5):829-42. PubMed ID: 16296781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for nano-particle based vaccine formulation and evaluation of their immunogenicity.
    Kalkanidis M; Pietersz GA; Xiang SD; Mottram PL; Crimeen-Irwin B; Ardipradja K; Plebanski M
    Methods; 2006 Sep; 40(1):20-9. PubMed ID: 16997710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of stabilized plasmid lipid particles and lipid nanoparticle encapsulated CpG containing oligodeoxynucleotides as a systemic genetic vaccine.
    Wilson KD; de Jong SD; Kazem M; Lall R; Hope MJ; Cullis PR; Tam YK
    J Gene Med; 2009 Jan; 11(1):14-25. PubMed ID: 19003796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticles for nasal vaccination.
    Csaba N; Garcia-Fuentes M; Alonso MJ
    Adv Drug Deliv Rev; 2009 Feb; 61(2):140-57. PubMed ID: 19121350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particulate delivery systems for animal vaccines.
    Scheerlinck JP; Greenwood DL
    Methods; 2006 Sep; 40(1):118-24. PubMed ID: 16997719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micro- and nanoparticulates for DNA vaccine delivery.
    Farris E; Brown DM; Ramer-Tait AE; Pannier AK
    Exp Biol Med (Maywood); 2016 May; 241(9):919-29. PubMed ID: 27048557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.
    Alpar HO; Somavarapu S; Atuah KN; Bramwell VW
    Adv Drug Deliv Rev; 2005 Jan; 57(3):411-30. PubMed ID: 15560949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide-based subunit nanovaccines.
    Skwarczynski M; Toth I
    Curr Drug Deliv; 2011 May; 8(3):282-9. PubMed ID: 21291373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technological advances to increase immunogenicity of DNA vaccines.
    Lemieux P
    Expert Rev Vaccines; 2002 Jun; 1(1):85-93. PubMed ID: 12908515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent advances in liposomes and nanoparticles as drug carriers for drug delivery].
    Liu Y; Lü WL; Zhang Q
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):583-9. PubMed ID: 16995319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An innovative method for quality control of conjugated Haemophilus influenzae vaccines: A short review of two-dimensional nanoparticle electrophoresis.
    Tietz D
    J Chromatogr A; 2009 Dec; 1216(52):9028-33. PubMed ID: 19733355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine delivery methods using viral vectors.
    Bråve A; Ljungberg K; Wahren B; Liu MA
    Mol Pharm; 2007; 4(1):18-32. PubMed ID: 17274663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficiency of a novel delivery system (PEI600-Tat) in development of potent DNA vaccine using HPV16 E7 as a model antigen.
    Bolhassani A; Ghasemi N; Servis C; Taghikhani M; Rafati S
    Drug Deliv; 2009 May; 16(4):196-204. PubMed ID: 19514980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.